{
  "title": "Best Practices For Patient Care",
  "source": "CDC",
  "chunk_id": 4,
  "content": "Immunization of infants\nless than 8 months\nwith nirsevimab, a monoclonal antibody administered during October through March (earlier is better) in most of the continental United States.\nChildren\nSome children aged\n8 through 19 months\nat increased risk for severe RSV disease should receive nirsevimab when entering their second RSV season.\nOlder adults\nEveryone\n75 years of age and older\nshould receive RSV vaccination if they haven't been previously vaccinated.\nAdults\n60 through 74 years"
}